SCHEMBL29922768

SCHEMBL29922768

COC(=O)c1nnc(Cl)cc1Nc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.46
▸ EGFR P00533 1/20 0.42
▸ GSK3B P49841 2/20 0.40
▸ LRRK2 Q5S007 3/20 0.40
▸ AVPR2 P30518 1/20 0.40
▸ GPR27 Q9NS67 1/20 0.40
▸ JAK2 O60674 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ TYK2 P29597 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ ALDH3A1 P30838 1/20 0.39
▸ TNIK Q9UKE5 1/20 0.39
▸ PIP4K2A P48426 1/20 0.39
▸ PIP4K2C Q8TBX8 1/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ CCNB2 O95067 1/20 0.38
▸ CCNE2 O96020 1/20 0.38
▸ CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359050 1.00 SYK (0.46) SYKEGFRGSK3BLRRK2AVPR2
SCHEMBL15091096 0.85 SYK (0.56) SYKNPC1RAB9AKDM4EALDH1A1
SCHEMBL15091106 0.83 LMNA (0.41) SYKLRRK2JAK2TYK2TNIK
SCHEMBL29922937 0.82 SYK (0.46) SYKRAB9AKDM4EALDH1A1
SCHEMBL29922724 0.82 SYK (0.46) SYKGSK3BCCNB2CCNE2CDK1
SCHEMBL28359017 0.82 SYK (0.46) SYKGSK3BCCNB2CCNE2CDK1
SCHEMBL28359009 0.82 SYK (0.46) SYKRAB9AKDM4EALDH1A1
SCHEMBL28362794 0.81 SYK (0.45) SYKLRRK2RAB9APTGS2KDM4E
SCHEMBL29922643 0.80 ALDH1A1 (0.47) SYKNPC1RAB9AKDM4EALDH1A1
SCHEMBL28359257 0.80 ALDH1A1 (0.47) SYKNPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
Send feedback